A rare cause of an ileocaecal mass and lymphadenopathy

Culver, Emma L.; Barnes, Eleanor; Delaney, David; Ellis, Antony J.; George, Bruce; Chapman, Roger W
June 2012
Gut;Jun2012, Vol. 61 Issue 6, p819
Academic Journal
A quiz concerning the diagnosis and treatment of an ileocaecal massand lymphadenopathy is presented.


Related Articles

  • Is Selective Neck Dissection Sufficient Treatment for the NO/Np+ Neck? Davidson, Jean; Khan, Yasser; Gilbert, Ralph; Birt, B. Derek; Balogh, Judith; MacKenzie, Robert // Journal of Otolaryngology;Jul/Aug1997, Vol. 26 Issue 4, p229 

    Evaluates the therapeutic role of selective neck dissection performed electively to lymph node negative (NO) patients. Percentage of patients that were clinically and pathologically NO; Development of minor postoperative wound infections; Development of recurrent disease in the neck; Success of...

  • COEXISTENCIA ENTRE POLIMIOSITIS Y ENFERMEDAD DE CASTLEMAN; PRESENTACIÓN DE UN CASO. Wong Lam, Antonio; Barbosa Cobos, Rosa; Cuesta Mejías, Cristina; Campozano Vásquez, Karla // Revista Medicina;2015, Vol. 19 Issue 1, p39 

    Coexistence between Castleman disease and idiopathic inflammatory polymyopathy is little known because there are few cases concerning these two diseases together. The histopathologic features of lymph nodes associated in these two entities are similar, making their differentiation more...

  • Factors that determine whether a patient receives completion axillary lymph node dissection after a positive sentinel lymph node biopsy for breast cancer in British Columbia. Aslani, Nava; Swanson, Todd; Kennecke, Hagen; Woods, Ryan; Davis, Noelle // Canadian Journal of Surgery;Aug2011, Vol. 54 Issue 4, p237 

    Background: Completion axillary lymph node dissection (CALND) is recommended in the setting of positive sentinel lymph node biopsy (SLNB) but is associated with a higher rate of postoperative complications. In this study, the characteristics and outcomes of patients who did and did not have...

  • High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for High-Risk Breast Cancer. Rodenhuis, Sjoerd; Bontenbal, Marijke; Beex, Louk V.A.M.; Wagstaff, John; Richel, Dick J.; Nooij, Marianne A.; Voest, Emile E.; Hupperets, Pierre; van Tinteren, Harm; Peterse, Hans L.; TenVergert, Elisabeth M.; de Vries, Elisabeth G.E. // New England Journal of Medicine;7/3/2003, Vol. 349 Issue 1, p7 

    Background: The use of high-dose adjuvant chemotherapy for high-risk primary breast cancer is controversial. We studied its efficacy in patients with 4 to 9 or 10 or more tumor-positive axillary lymph nodes. Methods: Patients younger than 56 years of age who had undergone surgery for breast...

  • Conventional Adjuvant Chemotherapy with or without High-Dose Chemotherapy and Autologous Stem-Cell Transplantation in High-Risk Breast Cancer. Tallman, Martin S.; Gray, Robert; Robert, Nicholas J.; LeMaistre, Charles F.; Osborne, C. Kent; Vaughan, William P.; Gradishar, William J.; Pisansky, Thomas M.; Fetting, John; Paietta, Elisabeth; Lazarus, Hillard M. // New England Journal of Medicine;7/3/2003, Vol. 349 Issue 1, p17 

    Background: The prognosis for women with primary breast cancer and 10 or more involved axillary lymph nodes is poor. High-dose chemotherapy with autologous hematopoietic stem-cell transplantation has been reported to be effective in the adjuvant setting for patients at high risk for relapse....

  • CALCIFIED LYMPH NODES. Paquette, Manon; Terezhalmy, Geza T.; Moore, William S. // Quintessence International;Jul/Aug2003, Vol. 34 Issue 7, p562 

    The article discusses calcified lymph nodes, which are defined as markers for active or latent nodal diseases. The clinical presentation of calcified lymph nodes is reviewed, noting that patients with these nodes may complain of neck pain. The treatment process for calcified lymph nodes is also...

  • Efficacy and safety of covered self-expandable metal stents for management of distal malignant biliary obstruction due to lymph node metastases. Kawakubo, Kazumichi; Isayama, Hiroyuki; Nakai, Yousuke; Togawa, Osamu; Sasahira, Naoki; Kogure, Hirofumi; Sasaki, Takashi; Matsubara, Saburo; Yamamoto, Natsuyo; Hirano, Kenji; Tsujino, Takeshi; Toda, Nobuo; Tada, Minoru; Omata, Masao; Koike, Kazuhiko // Surgical Endoscopy;Sep2011, Vol. 25 Issue 9, p3094 

    Background: Distal malignant biliary obstruction (MBO) due to lymph node metastases (LNM) is a common problem in advanced malignant disease. However, the role of covered self-expandable metal stents (SEMS) in treating MBO has not been studied. The aim of this study was to evaluate the efficacy...

  • Metastatic malignant soft tissue myoepithelioma: a case report showing complete response after locoregional and systemic therapy. Rastrelli, M.; Passuello, N.; Cecchin, D.; Basso, U.; Tosi, A.L.; Rossi, C.R. // Journal of Surgical Case Reports;Dec2013, Vol. 2013 Issue 12, p1 

    We report on the case of a 61-year-old man with a soft tissue malignant myoepithelioma of the second toe of the right foot. After removal of the primary tumor, the patient developed in-transit metastases of the limb that we later treated with limb perfusion, using extracorporeal circulation with...

  • Intensity-modulated radiotherapy (IMRT) to prostate and pelvic nodes-is pelvic lymph node coverage adequate with fiducial-based image-guided radiotherapy? EMINOWICZ, G.; DEAN, C.; SHOFFREN, O.; MACDOUGALL, N.; WELLS, P.; MUIRHEAD, R. // British Journal of Radiology;May2014, Vol. 87 Issue 1037, p1 

    Objective: There remains concern regarding the use of fiducial-based image-guided radiotherapy (IGRT) in patients with high-risk prostate cancer also undergoing intensity-modulated radiotherapy (IMRT) to pelvic nodes. By a retrospective study, we aim to ascertain the impact of the use of...


Read the Article


Sign out of this library

Other Topics